Compare ELAN & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | PEN |
|---|---|---|
| Founded | 1954 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 12.8B |
| IPO Year | 2018 | 2015 |
| Metric | ELAN | PEN |
|---|---|---|
| Price | $23.91 | $316.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 16 |
| Target Price | $27.89 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 4.9M | 380.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | 0.11 | ★ 0.82 |
| Revenue | ★ $4,715,000,000.00 | $1,403,665,000.00 |
| Revenue This Year | $8.21 | $14.34 |
| Revenue Next Year | $5.31 | $13.71 |
| P/E Ratio | ★ $220.09 | $386.83 |
| Revenue Growth | 6.22 | ★ 17.50 |
| 52 Week Low | $13.23 | $221.26 |
| 52 Week High | $27.72 | $362.41 |
| Indicator | ELAN | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 33.90 |
| Support Level | $23.72 | $302.19 |
| Resistance Level | $24.06 | $322.24 |
| Average True Range (ATR) | 1.04 | 2.33 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 34.15 | 17.97 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.